ACTG Publications

TitleAuthorsDateJournalIssueVolume
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.Weinberg, Adriana ; Bosch, Ronald ; Bennett, Kara ; Tovar-Salazar, Adriana ; Benson, Constance A ; Collier, Ann C ; Zolopa, Andrew ; Gulick, Roy M ; Wohl, David ; Polsky, Bruce ; Erice, Alejo ; Jacobson, Mark A2014 May 1J Acquir Immune Defic Syndr166
Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy.Bosch, Ronald J ; Bennett, Kara ; Collier, Ann C ; Zackin, Robert ; Benson, Constance A2007 Mar 1J Acquir Immune Defic Syndr344
Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV.Schacker, Timothy W ; Bosch, Ronald J ; Bennett, Kara ; Pollard, Richard ; Robbins, Gregory K ; Collier, Ann C ; Gulick, Roy M ; Spritzler, John ; Mildvan, Donna ; AIDS Clinical Trials Group2010 May 1J Acquir Immune Defic Syndr154
Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy.Palermo, Brandon ; Bosch, Ronald J ; Bennett, Kara ; Jacobson, Jeffrey M2011 Jul-AugHIV Clin Trials412
Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals.Hoffman, Risa M ; Jamieson, Beth D ; Bosch, Ronald J ; Currier, Judith ; Kitchen, Christina M R ; Schmid, Ingrid ; Zhu, Yuda ; Bennett, Kara ; Mitsuyasu, Ronald2011 OctJ Clin Immunol531